(Bloomberg) -- For Spain’s billionaire Grifols family, which turned a blood-collection business into one of the world’s largest medical fortunes, Brookfield Asset Management’s plan to take ...

Last year, executive chairman Thomas Glanzmann stepped into the chief executive role, ending the long-standing tradition of a Grifols family member being at the helm. He replaced co-CEOs Victor ...

Grifols shares lost more than 5% on the stock market on Monday. Last Friday, after the market had closed, a report was ...